Ludtmann Marthe H R, Angelova Plamena R, Ninkina Natalia N, Gandhi Sonia, Buchman Vladimir L, Abramov Andrey Y
Department of Molecular Neuroscience, University College London Institute of Neurology, London WC1N 3BG, United Kingdom, and.
School of Biosciences, University of Cardiff, Cardiff CF10 3AX, United Kingdom.
J Neurosci. 2016 Oct 12;36(41):10510-10521. doi: 10.1523/JNEUROSCI.1659-16.2016.
Misfolded α-synuclein is a key factor in the pathogenesis of Parkinson's disease (PD). However, knowledge about a physiological role for the native, unfolded α-synuclein is limited. Using brains of mice lacking α-, β-, and γ-synuclein, we report that extracellular monomeric α-synuclein enters neurons and localizes to mitochondria, interacts with ATP synthase subunit α, and modulates ATP synthase function. Using a combination of biochemical, live-cell imaging and mitochondrial respiration analysis, we found that brain mitochondria of α-, β-, and γ-synuclein knock-out mice are uncoupled, as characterized by increased mitochondrial respiration and reduced mitochondrial membrane potential. Furthermore, synuclein deficiency results in reduced ATP synthase efficiency and lower ATP levels. Exogenous application of low unfolded α-synuclein concentrations is able to increase the ATP synthase activity that rescues the mitochondrial phenotypes observed in synuclein deficiency. Overall, the data suggest that α-synuclein is a previously unrecognized physiological regulator of mitochondrial bioenergetics through its ability to interact with ATP synthase and increase its efficiency. This may be of particular importance in times of stress or PD mutations leading to energy depletion and neuronal cell toxicity.
Misfolded α-synuclein aggregations in the form of Lewy bodies have been shown to be a pathological hallmark in histological staining of Parkinson's disease (PD) patient brains. It is known that misfolded α-synuclein is a key driver in PD pathogenesis, but the physiological role of unfolded monomeric α-synuclein remains unclear. Using neuronal cocultures and isolated brain mitochondria of α-, β-, and γ-synuclein knock-out mice and monomeric α-synuclein, this current study shows that α-synuclein in its unfolded monomeric form improves ATP synthase efficiency and mitochondrial function. The ability of monomeric α-synuclein to enhance ATP synthase efficiency under physiological conditions may be of importance when α-synuclein undergoes the misfolding and aggregation reported in PD.
错误折叠的α-突触核蛋白是帕金森病(PD)发病机制中的关键因素。然而,关于天然未折叠的α-突触核蛋白的生理作用的了解有限。利用缺乏α-、β-和γ-突触核蛋白的小鼠大脑,我们报告细胞外单体α-突触核蛋白进入神经元并定位于线粒体,与ATP合酶亚基α相互作用,并调节ATP合酶功能。通过生化、活细胞成像和线粒体呼吸分析相结合的方法,我们发现α-、β-和γ-突触核蛋白敲除小鼠的脑线粒体解偶联,其特征是线粒体呼吸增加和线粒体膜电位降低。此外,突触核蛋白缺乏导致ATP合酶效率降低和ATP水平降低。外源应用低浓度未折叠的α-突触核蛋白能够增加ATP合酶活性,挽救在突触核蛋白缺乏中观察到的线粒体表型。总体而言,数据表明α-突触核蛋白通过其与ATP合酶相互作用并提高其效率的能力,是线粒体生物能量学先前未被认识的生理调节因子。这在应激或导致能量消耗和神经元细胞毒性的PD突变时期可能尤为重要。
路易小体形式的错误折叠α-突触核蛋白聚集体已被证明是帕金森病(PD)患者脑组织学染色中的病理标志。已知错误折叠的α-突触核蛋白是PD发病机制中的关键驱动因素,但未折叠单体α-突触核蛋白的生理作用仍不清楚。利用α-、β-和γ-突触核蛋白敲除小鼠和单体α-突触核蛋白的神经元共培养物和分离的脑线粒体,本研究表明未折叠单体形式的α-突触核蛋白可提高ATP合酶效率和线粒体功能。在生理条件下,单体α-突触核蛋白增强ATP合酶效率的能力在α-突触核蛋白发生PD中报道的错误折叠和聚集时可能很重要。